{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T23:11:55Z","timestamp":1717283515364},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s13300-014-0078-7","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T06:56:41Z","timestamp":1409036201000},"page":"403-413","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Randomized Trial of Step-up Treatment with Premixed Insulin Lispro-50\/50 vs. Aspart-70\/30 in Patients with Type 2 Diabetes Mellitus"],"prefix":"10.1007","volume":"5","author":[{"given":"Nozomi","family":"Domeki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Monden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Aso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"key":"78_CR1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","volume":"28","author":"Y Ohkubo","year":"1995","unstructured":"Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103\u201317.","journal-title":"Diabetes Res Clin Pract"},{"key":"78_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1055\/s-2006-924424","volume":"114","author":"RJ Ligthelm","year":"2006","unstructured":"Ligthelm RJ, Mouritzen U, Lyggaard H, et al. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomized open-label parallel group four months comparison in patients with type 2 diabetes. Exp Clin Endcrinol Diabetes. 2006;114:511\u20139.","journal-title":"Exp Clin Endcrinol Diabetes"},{"key":"78_CR3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1463-1326.2008.00897.x","volume":"10","author":"H Masuda","year":"2008","unstructured":"Masuda H, Sakamoto M, Irie J, Kitaoka A, Shiono K, Inoue G, Atsuda K, Yamada S. Copparison of twice-daily injections of biphasic insulin lispro and basal-bolus therapy: glycaemic control and quality-of-life of insulin-na\u00efve type 2 diabetic patients. Diabetes Obes Metab. 2008;10:1261\u20135.","journal-title":"Diabetes Obes Metab"},{"key":"78_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"United Kingdom Prospective Diabetes (UKPDS) Group","year":"1998","unstructured":"United Kingdom Prospective Diabetes (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837\u201353.","journal-title":"Lancet"},{"key":"78_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.diabres.2007.08.011","volume":"79","author":"K Hirao","year":"2008","unstructured":"Hirao K, Arai K, Yamauchi M, Takagi H, Kobayashi M. Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM11). Diabetes Res Clin Pract. 2008;79:171\u20136.","journal-title":"Diabetes Res Clin Pract"},{"key":"78_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1475-2840-7-16","volume":"7","author":"Y Miyashita","year":"2008","unstructured":"Miyashita Y, Nishimura R, Nemoto M, Matsudaira T, Kurata H, Yokota T, Yokota K, Tojo K, Utsunomiya K, Tajima N. Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure. Cardiovasc Diabetol. 2008;7:16\u201324.","journal-title":"Cardiovasc Diabetol"},{"key":"78_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0140-6736(08)60485-7","volume":"371","author":"RG Bretzel","year":"2008","unstructured":"Bretzel RG, Nuber U, Landgraf W, Owens D, Bradley C, Linn T. Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomized controlled trial. Lancet. 2008;371:1073\u201384.","journal-title":"Lancet"},{"key":"78_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1463-1326.2005.00563.x","volume":"8","author":"AJ Garber","year":"2006","unstructured":"Garber AJ, Wahlen T, Wahl T, Bressler P, Braceras R, Allen E, Jain R. Attainment of glycaemic goals in type 2 diabetes with once-, twice, or thrice-daily dosing with biphasic insulin aspart 70\/30 (The 1-2-3 study). Diabetes Obes Metab. 2006;8:58\u201366.","journal-title":"Diabetes Obes Metab"},{"key":"78_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1742-1241.2009.02002.x","volume":"63","author":"P Valensi","year":"2009","unstructured":"Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30\/70 (NovoMixR 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVETM observational study. Int J Clin Pract. 2009;63:522\u201331.","journal-title":"Int J Clin Pract"},{"key":"78_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diabres.2009.04.012","volume":"85","author":"N Yoshioka","year":"2009","unstructured":"Yoshioka N, Kurihara Y, Manda N, Komori K, Kato M, Kijima H, Wada N, Yanagisawa K, Aoki S, Ono Y, Koike T. Atep-up therapy with biphasic insulin aspart-70\/30-Sapporo 1-2-3 study. Diabetes Res Clin Pract. 2009;85:47\u201352.","journal-title":"Diabetes Res Clin Pract"},{"key":"78_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0149-2918(00)88307-1","volume":"21","author":"P Roach","year":"1999","unstructured":"Roach P, Trautmann M, Arora V, Sun B, Anderson JH Jr. Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro mix25 and insulin lispro mix50. Mix50 Study Group. Clin Ther. 1999;21:523\u201334.","journal-title":"Clin Ther"},{"key":"78_CR12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1055\/s-2004-814345","volume":"36","author":"G Schernthaner","year":"2004","unstructured":"Schernthaner G, Kopp HP, Ristic S, Muzyka B, Peter L, Mitteregger G. Metabolic control in patients with type 2 diabetes using Humalog Mix50 injected three times daily: crossover comp with human insulin 30\/70. Horm Metab Res. 2004;36:188\u201393.","journal-title":"Horm Metab Res"},{"key":"78_CR13","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.clinthera.2007.11.016","volume":"29","author":"DC Robbins","year":"2007","unstructured":"Robbins DC, Beisswnger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH. Mealtime 50\/50 basal\u00a0+\u00a0prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Clin Ther. 2007;29:2349\u201364.","journal-title":"Clin Ther"},{"key":"78_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1507\/endocrj.K10E-307","volume":"58","author":"Y Hosoi","year":"2011","unstructured":"Hosoi Y, Ohtani K, Shimizu H, Kashima K, Sato N, Akiyama H, Mori M. Attainment of glycaemic goals by step-up therapy with biphasic insulin aspart-70\/30 in Japanese type 2 diabetic patients. Endcrine J. 2011;58:131\u20135.","journal-title":"Endcrine J."},{"key":"78_CR15","doi-asserted-by":"publisher","first-page":"b4324","DOI":"10.1136\/bmj.b4324","volume":"339","author":"SS Lund","year":"2009","unstructured":"Lund SS, Tamow L, Frandsen M, Nielsen BB, Hansen BV, Pedersen O, Parving HH, Naag AA. Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12\u00a0month, randomized, double blind trial. BMJ. 2009;339:b4324.","journal-title":"BMJ"},{"key":"78_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1056-8727(03)00076-X","volume":"17","author":"C Kilo","year":"2003","unstructured":"Kilo C, Mezitis N, Jain R, Mersey J, McGill J, Raskin P. Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70\/30, both biphasic human insulin 70\/30, or NPH insulin in combination with metformin. J Diabetes Complicat. 2003;17:307\u201313.","journal-title":"J Diabetes Complicat"},{"key":"78_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1046\/j.1463-1326.2003.00277.x","volume":"5","author":"P Roach","year":"2003","unstructured":"Roach P, Arova V, Campaigne BN, Mattoo V, Rangwala SH. Humalog Mix50 before carbohydrate-rich meals in type 2 diabetes mellitus. Diabetes Obes Metab. 2003;5:311\u20136.","journal-title":"Diabetes Obes Metab"},{"key":"78_CR18","first-page":"970","volume":"1","author":"H Dorchy","year":"1994","unstructured":"Dorchy H. What glycemic control can be achieved in young diabetics without residual secretion of endogenous insulin? What is the frequency of severe hypoglycemia and subclinical complication? Arch Pediatr. 1994;1:970\u201381 (French).","journal-title":"Arch Pediatr."},{"key":"78_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0095-4543(03)00043-5","volume":"30","author":"J Albu","year":"2003","unstructured":"Albu J, Raja-Khan N. The management of the obese diabetic patient. Prim Care. 2003;30:465\u201391.","journal-title":"Prim Care"},{"key":"78_CR20","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.diabres.2004.07.005","volume":"65S","author":"S Heller","year":"2004","unstructured":"Heller S. Weight gain during insulin therapy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2004;65S:S23\u20137.","journal-title":"Diabetes Res Clin Pract"},{"key":"78_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1463-1326.2008.00844.x","volume":"10","author":"M Davies","year":"2008","unstructured":"Davies M, Khunti K. Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine. Diabetes Obese Metab. 2008;10:42\u20139.","journal-title":"Diabetes Obese Metab"},{"key":"78_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.diabres.2006.01.013","volume":"73","author":"M Kobayashi","year":"2006","unstructured":"Kobayashi M, Yamazaki K, Hirao K, Oishi M, Kanatsuka A, Yamauchi M, Takagi H, Kawai K. The status of diabetes control and antidiabetic drug therapy in Japan-A cross-sectional survey of 17,000 patients with diabetic mellitus (JDDM 1). Diabetes Res Clin Pract. 2006;73:198\u2013204.","journal-title":"Diabetes Res Clin Pract"},{"key":"78_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/dom.12020","volume":"15","author":"W Kothny","year":"2013","unstructured":"Kothny W, Foley J, Kozlovsky P, Shao Q, Gallwitz B, Lukashevich V. Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2013;15:252\u20137.","journal-title":"Diabetes Obes Metab"},{"key":"78_CR24","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.2337\/dc12-2718","volume":"36","author":"H Yki-Jarvien","year":"2013","unstructured":"Yki-Jarvien H, Rosenstock J, Duran-Garcia S, Pinnetti S, Bhattacharya S, Thiemann S, Patel S, Woerle HJ. Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a \u226552-week randomized, double-blind study. Diabetes Care. 2013;36:3875\u201381.","journal-title":"Diabetes Care"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-014-0078-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13300-014-0078-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-014-0078-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-014-0078-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T22:32:38Z","timestamp":1717281158000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13300-014-0078-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s13300-014-0078-7","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]},"assertion":[{"value":"22 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2014","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}